Reduced ex vivo stimulated IL-6 response in infants randomized to fish oil from 9 to 18 months, especially among PPARG2 and COX2 wild types

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 94, Issue , 2015, Pages 21-27

  Harsløf, Laurine B S ^a   Damsgaard, Camilla T ^a   Andersen, Anders D ^a   Aakjær, Ditte L ^a   Michaelsen, Kim F ^a   Hellgren, Lars I ^b   Frøkiær, Hanne ^c   Vogel, Ulla ^d   Lauritzen, Lotte ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

Child nutrition; Immune maturation; Long chain n 3 polyunsaturated fatty acids; Microbiota; Polymorphisms

Indexed keywords

CYCLOOXYGENASE 2; FISH OIL; IMMUNOGLOBULIN E; INTERLEUKIN 6; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; RNA 16S; SUNFLOWER OIL; EDIBLE OIL; IL6 PROTEIN, HUMAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PTGS2 PROTEIN, HUMAN; VEGETABLE OIL;

ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DANISH CITIZEN; EX VIVO STUDY; FATTY ACID ANALYSIS; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; INFANT; INTESTINE FLORA; LACTOBACILLUS PARACASEI; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; BACTERIAL INFECTION; BLOOD; DRUG EFFECTS; FECES; GENETICS; IMMUNOLOGY; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA;

BACTERIA (MICROORGANISMS); HELIANTHUS; LACTOBACILLUS PARACASEI;

BACTERIAL INFECTIONS; CYCLOOXYGENASE 2; DIETARY FATS, UNSATURATED; FECES; FEMALE; FISH OILS; HUMANS; IMMUNOGLOBULIN E; INFANT; INTERLEUKIN-6; INTESTINES; MALE; MICROBIOTA; PLANT OILS; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA;

EID: 84924032747     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2014.10.007     Document Type: Article

References (45)

1. Kremmyda L.S., Vlachava M., Noakes P.S., Diaper N.D., Miles E.A., Calder P.C. Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review. Clin. Rev. Allergy Immunol. 2011, 41:36-66.
2. Sijben J.W., Calder P.C. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc. Nutr. Soc. 2007, 66:237-259.
3. Gottrand F. Long-chain polyunsaturated fatty acids influence the immune system of infants. J. Nutr. 2008, 138:1807S-1812S.
4. Field C.J., Clandinin M.T., Van Aerde J.E. Polyunsaturated fatty acids and T-cell function: implications for the neonate. Lipids 2001, 36:1025-1032.
5. Sigurs N., Hattevig G., Kjellman B., Kjellman N.I., Nilsson L., Bjorksten B. Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J. Allergy Clin. Immunol. 1994, 94:757-763.
6. Illi S., von Mutius E., Lau S., Nickel R., Gruber C., Niggemann B., Wahn U. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J. Allergy Clin. Immunol. 2004, 113:925-931.
7. Diehl S., Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 2002, 39:531-536.
8. Diehl S., Anguita J., Hoffmeyer A., Zapton T., Ihle J.N., Fikrig E., Rincon M. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 2000, 13:805-815.
9. Shih D.Q., Targan S.R. Immunopathogenesis of inflammatory bowel disease. World J. Gastroenterol. 2008, 14:390-400.
10. Kimura A., Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur. J. Immunol. 2010, 40:1830-1835.
11. Rincon M., Irvin C.G. Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int. J. Biol. Sci. 2012, 8:1281-1290.
12. Rhee K.J., Sethupathi P., Driks A., Lanning D.K., Knight K.L. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J. Immunol. 2004, 172:1118-1124.
13. Wang M., Karlsson C., Olsson C., Adlerberth I., Wold A.E., Strachan D.P., Martricardi P.M., Aberg N., Perkin M.R., Tripodi S., Coates A.R., Hesselmar B., Saalman R., Molin G., Ahrne S. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J. Allergy Clin. Immunol. 2008, 121:129-134.
14. Kalliomaki M., Kirjavainen P., Eerola E., Kero P., Salminen S., Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 2001, 107:129-134.
15. Sjogren Y.M., Tomicic S., Lundberg A., Bottcher M.F., Bjorksten B., Sverremark-Ekstrom E., Jenmalm M.C. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin. Exp. Allergy 2009, 39:1842-1851.
16. Kim E.J., Huws S.A., Lee M.R., Wood J.D., Muetzel S.M., Wallace R.J., Scollan N.D. Fish oil increases the duodenal flow of long chain polyunsaturated fatty acids and trans-11 18:1 and decreases 18:0 in steers via changes in the rumen bacterial community. J. Nutr. 2008, 138:889-896.
17. Andersen A.D., Molbak L., Michaelsen K.F., Lauritzen L. Molecular fingerprints of the human fecal microbiota from 9 to 18 months old and the effect of fish oil supplementation. J. Pediatr. Gastroenterol. Nutr. 2011, 53:303-309.
18. Andersen A.D., Molbak L., Thymann T., Michaelsen K.F., Lauritzen L. Dietary long-chain n-3 PUFA, gut microbiota and fat mass in early postnatal piglet development-exploring a potential interplay. Prostaglandins Leukot. Essent. Fatty Acids 2011, 85:345-351.
19. Field C.J., Thomson C.A., Van Aerde J.E., Parrott A., Euler A., Lien E., Clandinin M.T. Lower proportion of CD45R0+ cells and deficient interleukin-10 production by formula-fed infants, compared with human-fed, is corrected with supplementation of long-chain polyunsaturated fatty acids. J. Pediatr. Gastroenterol. Nutr. 2000, 31:291-299.
20. Lauritzen L., Kjaer T.M., Fruekilde M.B., Michaelsen K.F., Frokiaer H. Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2-year-old children. Lipids 2005, 40:669-676.
21. Damsgaard C.T., Lauritzen L., Kjaer T.M., Holm P.M., Fruekilde M.B., Michaelsen K.F., Frokiaer H. Fish oil supplementation modulates immune function in healthy infants. J. Nutr. 2007, 137:1031-1036.
22. Serhan C.N., Dalli J., Karamnov S., Choi A., Park C.K., Xu Z.Z., Ji R.R., Zhu M., Petasis N.A. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 2012, 26:1755-1765.
23. Andersen A.D., Michaelsen K.F., Hellgren L.I., Trolle E., Lauritzen L. A randomized controlled intervention with fish oil versus sunflower oil from 9 to 18 months of age: exploring changes in growth and skinfold thicknesses. Pediatr. Res. 2011, 70:368-374.
24. Harslof L.B., Damsgaard C.T., Hellgren L.I., Andersen A.D., Vogel U., Lauritzen L. Effects on metabolic markers are modified by PPARG2 and COX2 polymorphisms in infants randomized to fish oil. Genes Nutr. 2014, 9:396.
25. Harslof L.B., Larsen L.H., Ritz C., Hellgren L.I., Michaelsen K.F., Vogel U., Lauritzen L. FADS genotype and diet are important determinants of DHA status: a cross-sectional study in Danish infants. Am. J. Clin. Nutr. 2013, 97:1403-1410.
26. Lauritzen L., Jorgensen M., Mikkelsen T., Skovgaard I., Straarup E.M., Olsen S., Hoy C.E., Michaelsen K. Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes. Lipids 2004, 39:195-206.
27. Damsgaard C.T., Lauritzen L., Calder P.C., Kjaer T.M., Frokiaer H. Whole-blood culture is a valid low-cost method to measure monocytic cytokines-a comparison of cytokine production in cultures of human whole-blood, mononuclear cells and monocytes. J. Immunol. Methods 2009, 340:95-101.
28. Weiss G., Maaetoft-Udsen K., Stifter S.A., Hertzog P., Goriely S., Thomsen A.R., Paludan S.R., Frokiaer H. MyD88 drives the IFN-beta response to Lactobacillus acidophilus in dendritic cells through a mechanism involving IRF1, IRF3, and IRF7. J. Immunol. 2012, 189:2860-2868.
29. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
30. Masugi J., Tamori Y., Mori H., Koike T., Kasuga M. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem. Biophys. Res. Commun. 2000, 268:178-182.
31. Zhang X., Miao X., Tan W., Ning B., Liu Z., Hong Y., Song W., Guo Y., Zhang X., Shen Y., Qiang B., Kadlubar F.F., Lin D. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 2005, 129:565-576.
32. Vogel U., Segel S., Dethlefsen C., Tjonneland A., Saber A.T., Wallin H., Jensen M.K., Schmidt E.B., Andersen P.S., Overvad K. Associations between COX-2 polymorphisms, blood cholesterol and risk of acute coronary syndrome. Atherosclerosis 2010, 209:155-162.
33. Sanak M., Szczeklik W., Szczeklik A. Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma. J. Allergy Clin. Immunol. 2005, 116:221-223.
34. Vogel U., Christensen J., Nexo B.A., Wallin H., Friis S., Tjonneland A. Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis 2007, 28:427-434.
35. Campa D., Zienolddiny S., Maggini V., Skaug V., Haugen A., Canzian F. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 2004, 25:229-235.
36. Vogel U., Christensen J., Wallin H., Friis S., Nexo B.A., Tjonneland A. Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutat. Res. 2007, 617:138-146.
37. Damsgaard C.T., Schack-Nielsen L., Michaelsen K.F., Fruekilde M.B., Hels O., Lauritzen L. Fish oil affects blood pressure and the plasma lipid profile in healthy Danish infants. J. Nutr. 2006, 136:94-99.
38. Damsgaard C.T., Lauritzen L., Calder P.C., Kjaer T.R., Frokiaer H. Reduced ex vivo interleukin-6 production by dietary fish oil is not modified by linoleic acid intake in healthy men. J. Nutr. 2009, 139:1410-1414.
39. Martin H. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Mutat. Res. 2009, 669:1-7.
40. Van der Pouw Kraan T.C., Boeije L.C., Smeenk R.J., Wijdenes J., Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 1995, 181:775-779.
41. Kubo S., Takahashi H.K., Takei M., Iwagaki H., Yoshino T., Tanaka N., Mori S., Nishibori M. E-prostanoid (EP)2/EP4 receptor-dependent maturation of human monocyte-derived dendritic cells and induction of helper T2 polarization. J. Pharmacol. Exp. Ther. 2004, 309:1213-1220.
42. Bannenberg G., Serhan C.N. Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim. Biophys. Acta 1801, 2010:1260-1273.
43. Johnson G.H., Fritsche K. Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. J. Acad. Nutr. Diet. 2012, 112:1029-1041.
44. Blair I.A., Prakash C., Phillips M.A., Dougherty R.M., Iacono J.M. Dietary modification of omega 6 fatty acid intake and its effect on urinary eicosanoid excretion. Am. J. Clin. Nutr. 1993, 57:154-160.
45. Adam O., Tesche A., Wolfram G. Impact of linoleic acid intake on arachidonic acid formation and eicosanoid biosynthesis in humans. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79:177-181.